Grimes & Company Inc. trimmed its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 1.9% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,542 shares of the financial services provider’s stock after selling 201 shares during the quarter. Grimes & Company Inc.’s holdings in MetLife were worth $863,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Legal & General Group Plc increased its holdings in MetLife by 5.4% in the 2nd quarter. Legal & General Group Plc now owns 5,299,800 shares of the financial services provider’s stock worth $371,993,000 after acquiring an additional 269,246 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in MetLife by 1.5% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock worth $375,179,000 after acquiring an additional 68,579 shares in the last quarter. Nordea Investment Management AB increased its holdings in MetLife by 16.8% in the 4th quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock worth $347,735,000 after acquiring an additional 608,224 shares in the last quarter. Stifel Financial Corp increased its holdings in MetLife by 5.0% in the 3rd quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock worth $184,744,000 after acquiring an additional 105,762 shares in the last quarter. Finally, FMR LLC increased its holdings in MetLife by 5.4% in the 3rd quarter. FMR LLC now owns 2,209,119 shares of the financial services provider’s stock worth $182,208,000 after acquiring an additional 112,491 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.
MetLife Trading Down 0.9 %
NYSE MET opened at $85.96 on Friday. The firm’s 50-day moving average is $83.81 and its two-hundred day moving average is $79.98. MetLife, Inc. has a 12 month low of $64.61 and a 12 month high of $89.05. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $59.52 billion, a P/E ratio of 17.33, a PEG ratio of 0.65 and a beta of 1.07.
MetLife Dividend Announcement
Wall Street Analyst Weigh In
MET has been the subject of several recent analyst reports. Barclays boosted their price target on shares of MetLife from $90.00 to $96.00 and gave the stock an “overweight” rating in a report on Monday, January 6th. StockNews.com cut shares of MetLife from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. BMO Capital Markets initiated coverage on shares of MetLife in a research note on Thursday. They set a “market perform” rating and a $97.00 target price on the stock. Wells Fargo & Company lowered their target price on shares of MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a research note on Tuesday, January 14th. Finally, TD Cowen lifted their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a research note on Wednesday, November 27th. Two analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat.com, MetLife presently has a consensus rating of “Moderate Buy” and an average price target of $90.46.
Get Our Latest Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- What is the Australian Securities Exchange (ASX)
- Bloom Energy: Powering the Future With Decentralized Energy
- Market Cap Calculator: How to Calculate Market Cap
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- How Can Investors Benefit From After-Hours Trading
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.